Thanks largely to gains in the financial and industrial sectors the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is finishing the week strongly. In afternoon trade the index is up 0.4% to 5,807 points.
Unfortunately not all shares have been able to climb higher today. Four in particular are finishing the week deep in the red. They are as follows:
The Creso Pharma Ltd (ASX: CPH) share price has dropped 4% to 72 cents today. Despite today's decline the pot stock is still up by around 120% since the start of March. With no news out of the company, I believe today's decline is likely to be the result of traders taking profit.
The Freelancer Ltd (ASX: FLN) share price has fallen 3% to 88.7 cents. In January the company posted a strong full-year result which saw cash receipts rise 35% to $51.9 million. Despite this, Freelancer's shares have now edged 12% lower year-to-date. I think at the current price, Freelancer is worth a closer look.
The Harvey Norman Holdings Limited (ASX: HVN) share price has dropped 2.5% to $4.74. Whilst I was reasonably impressed with the company's recent half-year result, you won't find me investing in its shares at this point. I have major concerns over the impact the much speculated launch of Amazon in Australia could do to its overall profitability.
The Stemcell United Ltd (ASX: SCU) share price has dropped a massive 28% to 24.5 cents. Following a stellar run this week after announcing plans to enter the medical marijuana space, it appears as though traders are taking profit whilst they still can. Despite this drop its shares are still up around 1,700% this week.
